Vanguard Group’s X4 Pharmaceuticals XFOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$441K Sell
231,892
-37,025
-14% -$70.3K ﹤0.01% 3945
2025
Q1
$1.9M Sell
268,917
-4,446
-2% -$31.5K ﹤0.01% 3507
2024
Q4
$6.02M Sell
273,363
-7,995
-3% -$176K ﹤0.01% 3192
2024
Q3
$5.65M Buy
281,358
+5,023
+2% +$101K ﹤0.01% 3225
2024
Q2
$4.81M Buy
276,335
+15,411
+6% +$268K ﹤0.01% 3274
2024
Q1
$10.9M Sell
260,924
-6,038
-2% -$252K ﹤0.01% 2912
2023
Q4
$6.72M Buy
266,962
+6,138
+2% +$154K ﹤0.01% 3164
2023
Q3
$8.53M Buy
260,824
+1,253
+0.5% +$41K ﹤0.01% 2970
2023
Q2
$15.1M Buy
259,571
+114,761
+79% +$6.68M ﹤0.01% 2716
2023
Q1
$3.78M Buy
144,810
+25,464
+21% +$665K ﹤0.01% 3432
2022
Q4
$3.56M Buy
119,346
+12,409
+12% +$370K ﹤0.01% 3451
2022
Q3
$5.49M Buy
106,937
+83,098
+349% +$4.26M ﹤0.01% 3275
2022
Q2
$690K Buy
23,839
+2,066
+9% +$59.8K ﹤0.01% 4200
2022
Q1
$1.14M Sell
21,773
-9,335
-30% -$490K ﹤0.01% 4165
2021
Q4
$2.14M Sell
31,108
-37
-0.1% -$2.54K ﹤0.01% 4008
2021
Q3
$4.94M Buy
31,145
+1,224
+4% +$194K ﹤0.01% 3669
2021
Q2
$5.83M Buy
29,921
+5,368
+22% +$1.05M ﹤0.01% 3514
2021
Q1
$6.34M Buy
24,553
+54
+0.2% +$14K ﹤0.01% 3400
2020
Q4
$4.73M Buy
24,499
+586
+2% +$113K ﹤0.01% 3386
2020
Q3
$4.86M Sell
23,913
-108
-0.4% -$21.9K ﹤0.01% 3167
2020
Q2
$6.72M Sell
24,021
-614
-2% -$172K ﹤0.01% 2954
2020
Q1
$7.39M Buy
24,635
+612
+3% +$184K ﹤0.01% 2762
2019
Q4
$7.71M Buy
24,023
+5,959
+33% +$1.91M ﹤0.01% 2981
2019
Q3
$6.89M Buy
18,064
+637
+4% +$243K ﹤0.01% 3016
2019
Q2
$7.84M Buy
17,427
+14,551
+506% +$6.55M ﹤0.01% 2990
2019
Q1
$1.5M Buy
2,876
+1,108
+63% +$579K ﹤0.01% 3527
2018
Q4
$739K Buy
1,768
+180
+11% +$75.2K ﹤0.01% 3647
2018
Q3
$463K Hold
1,588
﹤0.01% 3866
2018
Q2
$1.04M Buy
1,588
+680
+75% +$444K ﹤0.01% 3675
2018
Q1
$3.74M Buy
+908
New +$3.74M ﹤0.01% 3256